Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Cash from Investing Activities (2020 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Cash from Investing Activities for 6 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 91.22% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $44.3 million through Dec 2025, down 23.05% year-over-year, with the annual reading at $44.3 million for FY2025, 23.05% down from the prior year.
  • Cash from Investing Activities hit $1.1 million in Q4 2025 for Bolt Biotherapeutics, down from $17.9 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $40.8 million in Q1 2022 to a low of -$190.5 million in Q1 2021.
  • Historically, Cash from Investing Activities has averaged -$71150.0 across 5 years, with a median of $13.1 million in 2023.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 1300.07% in 2021 and later surged 1664.52% in 2023.
  • Year by year, Cash from Investing Activities stood at $21.0 million in 2021, then fell by 21.86% to $16.4 million in 2022, then fell by 3.81% to $15.8 million in 2023, then decreased by 22.63% to $12.2 million in 2024, then crashed by 91.22% to $1.1 million in 2025.
  • Business Quant data shows Cash from Investing Activities for BOLT at $1.1 million in Q4 2025, $17.9 million in Q3 2025, and $10.8 million in Q2 2025.